GLAND / margins history

Follow the number, quarter by quarter.

Gland Pharma · EBITDA margin (%) across the available source records.

Research layer active

Metric history

EBITDA margin (%)

12 actual points
EBITDA margin (%)PositiveWatchNegative
12 actual records
Actual quarterly EBITDA margin (%) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 25 · Watch source sentiment · 2023-08-09Q1 FY24Q1 FY25: 19 · Watch source sentiment · 2024-08-14Q1 FY25Q1 FY26: 24 · Positive source sentiment · 2025-08-01Q1 FY26Q2 FY24: 23 · Watch source sentiment · 2023-11-09Q2 FY24Q2 FY25: 21 · Watch source sentiment · 2024-10-30Q2 FY25Q2 FY26: 21 · Positive source sentiment · 2025-11-06Q2 FY26Q3 FY24: 23 · Watch source sentiment · 2024-02-12Q3 FY24Q3 FY25: 26 · Watch source sentiment · 2025-01-23Q3 FY25Q3 FY26: 26 · Positive source sentiment · 2026-01-15Q3 FY26Q4 FY24: 23 · Positive source sentiment · 2024-05-14Q4 FY24Q4 FY25: 24 · Watch source sentiment · 2025-05-15Q4 FY25Q4 FY26: 30 · Positive source sentiment · 2026-05-15Q4 FY263019
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.
Q1 FY2425Q1 FY2519Q1 FY2624Q2 FY2423Q2 FY2521Q2 FY2621Q3 FY2423Q3 FY2526Q3 FY2626Q4 FY2423Q4 FY2524Q4 FY2630